Acetaminophen News and Research

RSS
The pain-reliever acetaminophen (also known as paracetomol) is one of the best-selling over-the-counter medications, used by more than 200 million Americans a year. It is sold under many brand names, including Tylenol, and is an ingredient in nearly 200 medications, both over-the-counter (such as Excedrin, Midol, NyQuil, and Sudafed) and prescription (such as Vicodin).
Labopharm completes joint venture with Gruppo Angelini

Labopharm completes joint venture with Gruppo Angelini

FDA assigns Cadence Pharmaceuticals' OFIRMEV NDA new PDUFA action date

FDA assigns Cadence Pharmaceuticals' OFIRMEV NDA new PDUFA action date

Australian TGA approves Acetadote for treatment of paracetamol poisoning

Australian TGA approves Acetadote for treatment of paracetamol poisoning

Scientists catch new mediators to develop novel treatments for diseases linked to inflammatory processes

Scientists catch new mediators to develop novel treatments for diseases linked to inflammatory processes

Labopharm's first-quarter fiscal 2010 revenues from product sales decrease $0.4M to $3.2M

Labopharm's first-quarter fiscal 2010 revenues from product sales decrease $0.4M to $3.2M

Cadence Pharmaceuticals resubmits OFIRMEV NDA

Cadence Pharmaceuticals resubmits OFIRMEV NDA

Conservative therapies need to be recommended over routine use of OTC cough/cold products in children

Conservative therapies need to be recommended over routine use of OTC cough/cold products in children

Conservative therapies recommended over routine use of OTC cough/cold products in children

Conservative therapies recommended over routine use of OTC cough/cold products in children

Nearly 85% of adolescents at risk of overdosing on acetaminophen: Study

Nearly 85% of adolescents at risk of overdosing on acetaminophen: Study

NeurogesX announces $40 million royalty financing agreement with Cowen Royalty

NeurogesX announces $40 million royalty financing agreement with Cowen Royalty

Labopharm, Gruppo Angelini sign agreement to commercialize OLEPTRO in the U.S.

Labopharm, Gruppo Angelini sign agreement to commercialize OLEPTRO in the U.S.

Jefferson Medical College surgeon uses artificial liver assist device as bridge to transplantation

Jefferson Medical College surgeon uses artificial liver assist device as bridge to transplantation

Patient preference study results of Kristalose to be presented at 2010 Digestive Disease Week meeting

Patient preference study results of Kristalose to be presented at 2010 Digestive Disease Week meeting

Bayer Diabetes Care launches DIDGET blood glucose monitoring system in the US

Bayer Diabetes Care launches DIDGET blood glucose monitoring system in the US

Physician panel to discuss issues related to Qutenza at Investor Day

Physician panel to discuss issues related to Qutenza at Investor Day

Labopharm launches INTELLITAB abuse and misuse-deterrent technology platform

Labopharm launches INTELLITAB abuse and misuse-deterrent technology platform

NDA for Cadence Pharmaceuticals' OFIRMEV injection to be re-submitted to FDA

NDA for Cadence Pharmaceuticals' OFIRMEV injection to be re-submitted to FDA

Primary care physician practices focus on improving patient outcomes

Primary care physician practices focus on improving patient outcomes

Ibuprofen demonstrates efficacy over acetaminophen for treatment of pain and fever

Ibuprofen demonstrates efficacy over acetaminophen for treatment of pain and fever

Enrollment complete in Jennerex' Phase 1 trial of JX-594 IV administration for solid tumors

Enrollment complete in Jennerex' Phase 1 trial of JX-594 IV administration for solid tumors